valuation thoughts, page-127

Checking the price of a small cap drug discovery biotech daily and worrying about dips causes lost sleep and stress.

Far better to look at the piprline and how it is being developed. As I said the next trial should be an approval one. They mentioned the chance of a PRV in a previous announcement as well.

If/when that happens any dip now will be a opportunity either taken or lost. The SOI is small. Half the shares are still in escrow foe another 12 months. zThe top 20 holders own 60% of the company.

So that does mean any large holder needing to sell will knock the price down. But conversely any big buyer is going to pump the price.

The price now is just noise.